Lineweaver Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.37M Buy
17,367
+1,128
+7% +$243K 0.52% 44
2026
Q1
$3.53M Buy
16,239
+849
+6% +$188K 0.48% 44
2025
Q4
$3.52M Buy
15,390
+755
+5% +$172K 0.48% 43
2025
Q3
$3.39M Sell
14,635
-1,414
-9% -$288K 0.5% 39
2025
Q2
$2.98M Buy
16,049
+1,093
+7% +$203K 0.47% 44
2025
Q1
$3.14M Sell
14,956
-44
-0.3% -$8.55K 0.53% 40
2024
Q4
$2.67M Buy
15,000
+2,626
+21% +$483K 0.49% 45
2024
Q3
$2.44M Buy
12,374
+288
+2% +$53.8K 0.47% 43
2024
Q2
$2.07M Buy
12,086
+10,065
+498% +$1.67M 0.43% 42
2024
Q1
$368K Buy
2,021
+11
+0.5% +$1.9K 0.09% 107
2023
Q4
$311K Sell
2,010
-474
-19% -$69.1K 0.08% 111
2023
Q3
$371K Buy
2,484
+33
+1% +$4.84K 0.11% 108
2023
Q2
$330K Buy
2,451
+113
+5% +$16.6K 0.09% 98
2023
Q1
$373K Buy
2,338
+106
+5% +$16.2K 0.11% 97
2022
Q4
$361K Buy
2,232
+18
+0.8% +$2.76K 0.11% 99
2022
Q3
$297K Buy
2,214
+183
+9% +$26.3K 0.1% 106
2022
Q2
$311K Buy
2,031
+568
+39% +$86.8K 0.1% 99
2022
Q1
$237K Buy
+1,463
New +$213K 0.07% 128

Other funds holding ABBV

Lineweaver Wealth Advisors's ABBV Position: Q2 2026 in Review

Lineweaver Wealth Advisors increased its AbbVie (ABBV) stake by 6.9% in Q2 2026, buying an estimated $243K and bringing the position to 17,367 shares worth $4.37M. The position accounts for 0.52% of the portfolio, ranked #44.

Lineweaver Wealth Advisors first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Lineweaver Wealth Advisors held 17,367 shares of AbbVie worth $4.37M as of Q2 2026.
  • Lineweaver Wealth Advisors bought 1,128 AbbVie shares in Q2 2026, an estimated $243K.
  • AbbVie made up 0.52% of Lineweaver Wealth Advisors's portfolio in Q2 2026, its #44 holding.
  • Lineweaver Wealth Advisors first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
  • 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lineweaver Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.